Brief: Senzime Gets Additional FDA Class II 510(K) Clearance For Tetragraph System
27/05/2026 13:04
BRIEF-Senzime Gets Additional FDA Class II 510(K) Clearance For Tetragraph System May 27 (Reuters) - Senzime AB (publ) SEZI.ST:
RECEIVES ADDITIONAL FDA CLASS II 510(K) CLEARANCE FOR TETRAGRAPH SYSTEM
Source text: ID:nMFN8mZwMZ
Further company coverage: SEZI.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com;))
Recent news on Senzime AB (publ)
See all newsBrief: Senzime Tetragraph System Receives Anvisa Approval For Sale In Brazil
Brief: Senzime Secures Contract With U.S. Hospital
Brief: Senzime Gets Additional FDA Class II 510(K) Clearance For Tetragraph System
Brief: Senzime's TetraGraph System Contracted On Three GPO Agreements In U.S.
Sweden's Senzime Q1 sales dip on weak US markets, strong krona